FDA Clearance Tracker · P080025-S046
MEDTRONIC INTERSTIM THERAPY SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 18, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Apr 18, 2014
Approved
Time to decision
436 days
Received Feb 6, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080025-S046
- Device name
- MEDTRONIC INTERSTIM THERAPY SYSTEM
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Feb 6, 2013
- Decided
- Apr 18, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080025
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MEDTRONICS VERIFY EVALUATION SYSTEM, WHICH IS A TEST STIMULATION SYSTEM CONSISTING OF THE MODEL 3537 CONTROLLER, THE MODEL 3531 VERIFY EXTERNAL NEUROSTIMULATOR (ENS), AND ASSOCIATED CABLES (MODELS 3575 AND 3576) AND ACCESSORIES.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.